145 related articles for article (PubMed ID: 3124731)
1. Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.
Barry AL; Miller GH; Thornsberry C; Hare RS; Jones RN; Lorber RR; Ferraresi R; Cramer C
Antimicrob Agents Chemother; 1987 Oct; 31(10):1514-8. PubMed ID: 3124731
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
Ismaeel NA
Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
[TBL] [Abstract][Full Text] [Related]
3. Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.
Clark RB; Sanders CC; Pakiz CB; Hostetter MK
Antimicrob Agents Chemother; 1988 May; 32(5):689-92. PubMed ID: 3134846
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.
Kabins SA; Nathan C; Cohen S
Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021
[TBL] [Abstract][Full Text] [Related]
5. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
Staneck JL; Glenn S; DiPersio JR; Leist PA
J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
[TBL] [Abstract][Full Text] [Related]
6. Netilmicin disk susceptibility tests: effect of cations on the MIC correlates.
Barry AL; Miller GH; Hare RS; Thornsberry C; Jones RN
Eur J Clin Microbiol; 1987 Aug; 6(4):416-7. PubMed ID: 3117533
[TBL] [Abstract][Full Text] [Related]
7. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
Briedis DJ; Robson HG
Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
Meyer RD; Draus LL; Pasieczinik KA
Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
[TBL] [Abstract][Full Text] [Related]
9. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.
Digranes A; Dibb WL; Benonisen E; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889
[TBL] [Abstract][Full Text] [Related]
10. Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides.
Barry AL; Reller LB; Miller GH; Washington JA; Schoenknect FD; Peterson LR; Hare RS; Knapp C
J Clin Microbiol; 1992 Mar; 30(3):585-9. PubMed ID: 1551973
[TBL] [Abstract][Full Text] [Related]
11. In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.
Dhawan V; Marso E; Martin WJ; Young LS
Antimicrob Agents Chemother; 1977 Jan; 11(1):64-73. PubMed ID: 836015
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of netilmicin susceptibility discs using bacteria with known aminoglycoside resistance patterns: correlation of in vitro and in vivo test results.
Waitz JA; Hare RS; Moss EL; Sabatelli FJ; Schaffer TW; Waitz JA
Scand J Infect Dis Suppl; 1980; Suppl 23():62-72. PubMed ID: 6937970
[TBL] [Abstract][Full Text] [Related]
13. Influence of medium composition on bacterial susceptibility testing to gentamicin and netilmicin.
Dornbusch K
Scand J Infect Dis Suppl; 1980; Suppl 23():46-53. PubMed ID: 6937968
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
Eickhoff TC; Ehret JM
Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli.
Hindler JA; Bruckner DA
J Clin Microbiol; 1987 Mar; 25(3):546-50. PubMed ID: 3571458
[TBL] [Abstract][Full Text] [Related]
16. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
Juhlin I; Tunevall G
Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of netilmicin, gentamicin, and amikacin.
Kantor RJ; Norden CW
Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
[TBL] [Abstract][Full Text] [Related]
18. Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa.
Omri A; Ravaoarinoro M; Poisson M
J Antimicrob Chemother; 1995 Oct; 36(4):631-9. PubMed ID: 8591937
[TBL] [Abstract][Full Text] [Related]
19. Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.
Barry AL; Miller GH; Hare RS; Jones RN; Thornsberry C
J Clin Microbiol; 1984 Mar; 19(3):311-4. PubMed ID: 6425354
[TBL] [Abstract][Full Text] [Related]
20. Amikacin and netilmicin resistance in Pseudomonas aeruginosa: incidence and transfer.
Knothe H; Krcméry V
Chemotherapy; 1979; 25(1):23-9. PubMed ID: 105839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
